Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.

PLoS One 2012 9;7(10):e47390. Epub 2012 Oct 9.

Department of Surgery, Institut Curie, Paris, France.

Introduction: To decipher the interaction between the molecular subtype classification and the probability of a non-sentinel node metastasis in breast cancer patients with a metastatic sentinel lymph-node, we applied two validated predictors (Tenon Score and MSKCC Nomogram) on two large independent datasets.

Materials And Methods: Our datasets consisted of 656 and 574 early-stage breast cancer patients with a metastatic sentinel lymph-node biopsy treated at first by surgery. We applied both predictors on the whole dataset and on each molecular immune-phenotype subgroups. The performances of the two predictors were analyzed in terms of discrimination and calibration. Probability of non-sentinel lymph node metastasis was detailed for each molecular subtype.

Results: Similar results were obtained with both predictors. We showed that the performance in terms of discrimination was as expected in ER Positive HER2 negative subgroup in both datasets (MSKCC AUC Dataset 1 = 0.73 [0.69-0.78], MSKCC AUC Dataset 2 = 0.71 (0.65-0.76), Tenon Score AUC Dataset 1 = 0.7 (0.65-0.75), Tenon Score AUC Dataset 2 = 0.72 (0.66-0.76)). Probability of non-sentinel node metastatic involvement was slightly under-estimated. Contradictory results were obtained in other subgroups (ER negative HER2 negative, HER2 positive subgroups) in both datasets probably due to a small sample size issue. We showed that merging the two datasets shifted the performance close to the ER positive HER2 negative subgroup.

Discussion: We showed that validated predictors like the Tenon Score or the MSKCC nomogram built on heterogeneous population of breast cancer performed equally on the different subgroups analyzed. Our present study re-enforce the idea that performing subgroup analysis of such predictors within less than 200 samples subgroup is at major risk of misleading conclusions.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0047390PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467227PMC
May 2013
27 Reads

Publication Analysis

Top Keywords

breast cancer
16
auc dataset
16
tenon score
16
node metastasis
12
her2 negative
12
probability non-sentinel
12
lymph node
12
metastatic sentinel
12
score auc
8
cancer patients
8
non-sentinel node
8
validated predictors
8
patients metastatic
8
score mskcc
8
positive her2
8
terms discrimination
8
mskcc auc
8
mskcc nomogram
8
negative her2
8
predictors tenon
8

Similar Publications